TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04786548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04521387 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06355544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06355544 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06550427 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05967884 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05967884 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04558918 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05088811 — Predictive Biomarker (PRD): WRAP53 mRNA
Genes: WRAP53; TCAB1; WDR79
Study NCT00002129 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05924269 — Predictive Biomarker (PRD): SEMA7A mRNA
Genes: SEMA7A; CD108; SEMAL
Study NCT05924269 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06551870 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT04775615 — Predictive Biomarker (PRD): DDO mRNA
Genes: DDO
Study NCT06480630 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04721977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05073471 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06251947 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT04861181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04861181 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04861181 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT04861181 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04503005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04503005 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04503005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06632912 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01154361 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06341205 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study NCT06349278 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05409404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05644925 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT05022914 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06084689 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05641896 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04478812 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04478812 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04908917 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02233257 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT05941936 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05062473 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06340659 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05478590 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05478590 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05478590 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05478590 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05730205 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04976257 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05743894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05096702 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05414370 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05414370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05375318 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study NCT05166876 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04896294 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05225831 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05225831 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04727008 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04727008 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06197490 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06472557 — Predictive Biomarker (PRD): ZFYVE9 mRNA
Genes: ZFYVE9; MADHIP; SARA; SMADIP
Study NCT04926181 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05360264 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05311865 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05040659 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04940806 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05323851 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05283837 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05169905 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06398587 — Predictive Biomarker (PRD): PLK1 mRNA
Genes: PLK1; PLK
Study NCT05502731 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04759131 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04759131 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT06188000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05186545 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04715256 — Predictive Biomarker (PRD): KCNQ1 mRNA
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study NCT06553846 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05662995 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05359068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06364527 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05052528 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06392126 — Predictive Biomarker (PRD): CHCHD10 mRNA
Genes: CHCHD10; C22orf16
Study NCT05386121 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05613842 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05783973 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04714671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04714671 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04714671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04714671 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04714671 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT04714671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05226377 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT05741086 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06055582 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05301634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05693090 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04688788 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06241950 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06280677 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT06242951 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05595954 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT05852288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05852288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05852288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06467734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06467734 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05467930 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05658549 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06464159 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06464159 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06464159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT03833310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06329999 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05838599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05838599 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05652842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00051597 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06118320 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06118320 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05555017 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05555017 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04553094 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT04375046 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04375046 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04402242 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study NCT05117476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT05117476 — Predictive Biomarker (PRD): MICB mRNA
Genes: MICB; PERB11.2
Study NCT05174377 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05174377 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05765734 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05765734 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04680039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05066633 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05066633 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05066633 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05439655 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT05341570 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04782193 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04782193 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05107349 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05593458 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06381843 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04826731 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05350423 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06120972 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05118269 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05009030 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04966429 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04961060 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT04796896 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04796896 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05395481 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT06347588 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06156176 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01048151 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05426291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04373941 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT05233176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05278091 — Predictive Biomarker (PRD): RFC1 mRNA
Genes: RFC1; RFC140
Study NCT05321940 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05891275 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06237491 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06293144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04980222 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04691232 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04691232 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT04691232 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05296278 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05091827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04462146 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05297708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05859048 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05382728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04831658 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04443829 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04597892 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04666298 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04666298 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05044988 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05044988 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06264622 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05085431 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05085431 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06101082 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06356948 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04496674 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05956587 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04871945 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04970108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06117137 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05268770 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05387577 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT05806021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000629 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT00000629 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05339386 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04819802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06433726 — Predictive Biomarker (PRD): TIPARP mRNA
Genes: TIPARP; PARP7
Study NCT05076123 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study NCT04870203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05474820 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT05474820 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06494163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06363500 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05729191 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04328194 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study NCT05436288 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06100484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06010615 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06010615 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05795335 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05795335 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04662411 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04992039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06225453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06476249 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06476249 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06476249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05494918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05396300 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06097572 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06511128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06091384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04935515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05364255 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05363800 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT00318604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT04877054 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05910398 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05910398 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05643508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05954689 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002017 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04753177 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04753177 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04753177 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05704439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05704439 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05330377 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05563974 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05548855 — Predictive Biomarker (PRD): LAMP2 mRNA
Genes: LAMP2
Study NCT04895124 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT04895124 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05861271 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06145074 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT06334900 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06549972 — Predictive Biomarker (PRD): KLK10 mRNA
Genes: KLK10; NES1; PRSSL1
Study NCT06549972 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05912712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05912712 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05912712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05912712 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04736329 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04736329 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06199622 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05737732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05055570 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT05842707 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05842707 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05314881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01344200 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01344200 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT06033664 — Surrogate Endpoint (SUR): Blood pressure